Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Biomolecules|June 24, 2022
Classical and Unexpected Effects of Ultra-Micronized PEA in Neuromuscular FunctionPierangelo Cifelli, Gabriele Ruffolo, Marco Ceccanti, et al.
International Journal of Molecular Sciences|July 2, 2021
An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?Miriam Sciaccaluga, Alfredo Megaro, Giovanni Bellomo, et al.
Current Pharmaceutical Design|August 12, 2017
Modulation of GABAA Receptors in the Treatment of EpilepsyEleonora Palma, Gabriele Ruffolo, Pierangelo Cifelli, et al.
Pharmacological Research|September 24, 2016
Pharmacological modulation in mesial temporal lobe epilepsy: Current status and future perspectivesAntonio Gambardella, Angelo Labate, Pierangelo Cifelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2005
Abnormal GABAA receptors from the human epileptic hippocampal subiculum microtransplanted to Xenopus oocytesEleonora Palma, Gabriele Spinelli, Gregorio Torchia, et al.
Frontiers in Neurology|May 22, 2025
Twitch force in human Amyotrophic Lateral SclerosisLaura Libonati, Chiara Cambieri, Marco Ceccanti, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 21, 2022
Lipid mediator n-3 docosapentaenoic acid-derived protectin D1 enhances synaptic inhibition of hippocampal principal neurons by interaction with a G-protein-coupled receptorApostolos Mikroulis, Marco Ledri, Gabriele Ruffolo, et al.
Life (Basel, Switzerland)|December 23, 2022
GABAergic Neurotransmission in Human Tissues Is Modulated by CannabidiolGabriele Ruffolo, Alessandro Gaeta, Beatrice Cannata, et al.
Neuropsychiatric Disease and Treatment|February 28, 2020
Cannabinoids in the Treatment of Epilepsy: Current Status and Future ProspectsAlessandra Morano, Martina Fanella, Mariarita Albini, et al.
International Journal of Molecular Sciences|January 26, 2020
Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?Pierangelo Cifelli, Gabriele Ruffolo, Eleonora De Felice, et al.
Pageof 7